Exagen Inc. (NASDAQ: XGN) reported Q3 EPS of ($0.31), $0.16 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $13.4 million versus the consensus estimate of $10.33 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.